AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 121 min read$KVUE

Howlett Heather sold $67K of KVUE

Howlett Heather (CFO & CAO) sold 3,700 shares of Kenvue Inc. (KVUE) at $18.10 on 2026-06-10.

Original reporting
SEC EDGAR · Howlett Heather
Published Jun 12, 2026, 8:11 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 12, 2026, 8:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$KVUE
Neutral
high confidence
Mentioned
$KVUE
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KVUENeutralLow
01

Why it matters

The disclosure updates the record of insider ownership after an open-market sale; it does not include guidance, litigation, product, or financial performance changes.

02

Market read

Traders may note the insider sale for sentiment, but there is no new fundamental catalyst in the text.

03

What to watch

The article does not state whether the sale was part of a 10b5-1 plan (it says 'No'), but it also provides no context on compensation, tax obligations, or prior trading patterns.

Relevance 3/10Novelty 2/10Timing: Filed 2026-06-12; sale executed 2026-06-10.

Background

The article summarizes an SEC Form 4 insider transaction for Kenvue (KVUE) by CFO & CAO Howlett Heather.

Company-level read

Ticker impact

$KVUENeutralHigh confidence
Context

Kenvue CFO & CAO Howlett Heather sold 3,700 KVUE shares in an open-market transaction on 2026-06-10 (Form 4).

Expected impact

Low near-term impact; any effect is likely sentiment-only and outweighed by normal trading noise.

Evidence & confidence

The filing is a disclosed insider sale (not a buy), but it is small in absolute terms and provides no new company-specific operational or financial catalyst.

Market effects

Sector

No clear sector read-through; this is company-specific insider transaction data.

Regional

None.

Global

None.

Counterpoint

What could challenge this read

Insider sales can be driven by diversification, taxes, or scheduled liquidity needs rather than bearish fundamentals—especially when not tied to a new negative event.

Key entities

  • insider
    Howlett Heather

    CFO & CAO of Kenvue; sold 3,700 shares via open-market sale.

  • issuer
    Kenvue Inc.

    Issuer of KVUE shares; insider sale disclosed on SEC EDGAR.

Read at source← All news

Related articles

AUG 7
$KMBMed

Kimberly-Clark to Consolidate Operations, Invest in Digital Optimizations Ahead of Kenvue Acquisition

Kimberly-Clark said it will consolidate 6,000 applications and more than 15 ERP systems as it nears completion of its Kenvue acquisition. On an earnings call, COO Russell Torres cited a three-year plan targeting $1.9 million in savings and identified over $600 million of savings, with system integration and supply chain and commercial integration as key drivers.

consumergoods.com4 min
AUG 6
$APPMed

Dow slips, Nasdaq moves level as earnings keep markets on edge

U.S. stocks opened mixed as investors digested earnings and economic data. AppLovin (APP) fell over 20% after Q2 revenue of $1.924B missed estimates. Datadog (DDOG) dropped over 18% on weaker bookings and guidance. SpaceX (SPCX) rose about 2.5% after a lockup expiry. Western Digital (WDC) slid 11% on margin outlook; Fiserv (FI) and Kenvue (KVUE) also fell.

proactiveinvestors.com7 min
AUG 6
$KVUEMed

Kenvue second quarter results fall short of expectations, sending shares lower

Kenvue (NYSE:KVUE) shares fell about 2% after its Q2 results narrowly missed Wall Street expectations. Adjusted diluted EPS was $0.31 vs $0.32 expected, and revenue was $3.96B vs $3.97B. Net sales rose 3%, but margins declined, with gross margin at 58.2% vs 58.9% a year earlier. Kenvue cited inflation, tariffs and FX and gave no forward guidance due to a planned Kimberly-Clark combination.

proactiveinvestors.com3 min
AUG 6
$KVUEMed

Kenvue misses quarterly estimates as inflation, tariffs squeeze margins

Kenvue reported Q2 adjusted profit of 31 cents per share, slightly below analysts’ 32 cents estimate, and sales rose 3% to $3.96 billion, just under the $3.97 billion forecast, according to LSEG. Adjusted gross margin fell to 60.2% from 60.9% as inflation, tariffs and currency costs pressured margins. Kenvue expects $250 million in 2026 pre-tax restructuring charges and says a $40 billion Kimberly-Clark buyout should close in Q4 2026.

yahoo.com3 min
AUG 6
$KVUEMedAI 8/10

Kenvue Inc. (KVUE): Results of Operations and Financial Condition

Kenvue Inc. (KVUE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q226earningspressrelease.htm EX-99.1 Document Kenvue Reports Second Quarter 2026 Results • Delivered Third Consecutive Quarter of Net and Organic Sales 1 Growth • Net Sales Increased 3.0%; Organic Sales Increased 1.6% • Diluted EPS Increased 9% to $0.24; Adjusted Dilute

SEC EDGAR 8-K6 min
JUL 31
$KVUEMedAI 8/10

FDA approves long-lasting OTC pain reliever combining acetaminophen and naproxen

The FDA approved an OTC pain reliever combining acetaminophen and naproxen sodium, marketed by Kenvue as Tylenol with Naproxen. Kenvue says it starts working within 30 minutes and lasts up to 12 hours, and cites eight studies showing better relief than either ingredient alone. The FDA allows use for temporary relief of minor aches and pains in adults and children 12+.

kztv10.com3 min